CUSIP 69366J200 · who reports it, how much, and how much it matters to them
36 of the 720 hedge fund managers we track reported shares of PTC Therapeutics, Inc. (Nasdaq: PTCT) on Form 13F for 30 June 2026. Between them they reported USD 1.2bn. The largest position belongs to RTW Investments, at USD 632m. The manager with the most riding on it is Palo Alto Investors, where it is 10.4% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | RTW Investments2 funds on PPLI.com | USD 632m | 5.4% |
| 2 | D. E. Shaw & Co.15 funds on PPLI.com | USD 126m | 0.1% |
| 3 | Armistice Capital1 fund on PPLI.com | USD 87m | 1.1% |
| 4 | Palo Alto Investors6 funds on PPLI.com | USD 75m | 10.4% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 61m | 0.0% |
| 6 | Renaissance Technologies13 funds on PPLI.com | USD 59m | 0.1% |
| 7 | Marshall Wace LLP84 funds on PPLI.com | USD 57m | 0.0% |
| 8 | Boxer Capital Management1 fund on PPLI.com | USD 16m | 1.2% |
| 9 | Rock Springs Capital Management2 funds on PPLI.com | USD 13m | 0.6% |
| 10 | Hudson Bay Capital Management8 funds on PPLI.com | USD 13m | 0.0% |
| 11 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 12m | 0.0% |
| 12 | Aquatic Capital Management3 funds on PPLI.com | USD 6.8m | 0.2% |
| 13 | Moore Capital Management7 funds on PPLI.com | USD 6.2m | 0.1% |
| 14 | Capricorn Fund Managers8 funds on PPLI.com | USD 5.2m | 0.4% |
| 15 | Exoduspoint Capital Management7 funds on PPLI.com | USD 4.7m | 0.0% |
| 16 | Orbimed Advisors1 fund on PPLI.com | USD 4m | 0.1% |
| 17 | Millennium Management6 funds on PPLI.com | USD 3.8m | 0.0% |
| 18 | Engineers Gate Manager1 fund on PPLI.com | USD 2.2m | 0.0% |
| 19 | Balyasny Asset Management25 funds on PPLI.com | USD 1.7m | 0.0% |
| 20 | Walleye Capital8 funds on PPLI.com | USD 1.6m | 0.0% |
| 21 | Verition Fund Management3 funds on PPLI.com | USD 1.2m | 0.0% |
| 22 | Landscape Capital Management4 funds on PPLI.com | USD 1.2m | 0.1% |
| 23 | Capital Fund Management S.A.12 funds on PPLI.com | USD 1.1m | 0.0% |
| 24 | Tudor Investment Corporation10 funds on PPLI.com | USD 1.1m | 0.0% |
| 25 | Lighthouse Investment Partners190 funds on PPLI.com | USD 914,000 | 0.0% |
| 26 | Two Sigma Investments35 funds on PPLI.com | USD 869,000 | 0.0% |
| 27 | Cinctive Capital Management5 funds on PPLI.com | USD 614,000 | 0.0% |
| 28 | Voleon Capital Management13 funds on PPLI.com | USD 550,000 | 0.0% |
| 29 | Capstone Investment Advisors25 funds on PPLI.com | USD 480,000 | 0.0% |
| 30 | Freestone Grove Partners1 fund on PPLI.com | USD 382,000 | 0.0% |
| 31 | Entrypoint Capital1 fund on PPLI.com | USD 379,000 | 0.1% |
| 32 | CIBC Asset Management69 funds on PPLI.com | USD 209,000 | 0.0% |
| 33 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 104,000 | 0.0% |
| 34 | Bayforest Capital1 fund on PPLI.com | USD 48,942 | 0.0% |
| 35 | The Quarry1 fund on PPLI.com | USD 2,284 | 0.0% |
| 36 | Summit Global Investments1 fund on PPLI.com | USD 615 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Palo Alto Investors | USD 75m | 10.4% |
| 2 | RTW Investments | USD 632m | 5.4% |
| 3 | Boxer Capital Management | USD 16m | 1.2% |
| 4 | Armistice Capital | USD 87m | 1.1% |
| 5 | Rock Springs Capital Management | USD 13m | 0.6% |
| 6 | Capricorn Fund Managers | USD 5.2m | 0.4% |
| 7 | Aquatic Capital Management | USD 6.8m | 0.2% |
| 8 | Entrypoint Capital | USD 379,000 | 0.1% |
| 9 | Moore Capital Management | USD 6.2m | 0.1% |
| 10 | Renaissance Technologies | USD 59m | 0.1% |
PTC Therapeutics, Inc. trades under the symbol PTCT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 69366J200.
36 of the 720 hedge fund managers PPLI.com tracks reported PTC Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by RTW Investments (USD 632m), D. E. Shaw & Co. (USD 126m), Armistice Capital (USD 87m), Palo Alto Investors (USD 75m) and Citadel Advisors (USD 61m).
36 managers in our coverage reported it, and between them they run 638 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Palo Alto Investors, where the position was 10.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with PTC Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.